Cargando…
Studying Abnormal Chromosomal Diseases Using Patient-Derived Induced Pluripotent Stem Cells
Chromosomal abnormality causes congenital and acquired intractable diseases. In general, there are no fundamental treatments for these diseases. To establish platforms to develop therapeutics for these diseases, patient-derived induced pluripotent stem cells (iPSCs) are highly beneficial. To study a...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456929/ https://www.ncbi.nlm.nih.gov/pubmed/32922264 http://dx.doi.org/10.3389/fncel.2020.00224 |